search
Back to results

Fluid Resuscitation in Septic Shock Patients With BMI Elevation (FRISSBE)

Primary Purpose

Sepsis, Septic Shock, Obesity

Status
Terminated
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Actual Body Weight Dosing
Adjusted Body Weight Dosing
Ideal Body Weight Dosing
Sponsored by
Wake Forest University Health Sciences
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Sepsis

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • 18 years of age or older
  • BMI > 30
  • suspected infection, and either:

    • hypotension (a systolic blood pressure < 90mmHg) or
    • blood lactate concentration > 4mmol/L

Exclusion Criteria:

  • Pregnant
  • Primary diagnosis of acute cerebral vascular event
  • Acute coronary syndrome
  • Acute pulmonary edema
  • Status asthmaticus
  • Major cardiac arrhythmia
  • Active gastrointestinal hemorrhage
  • Seizures
  • Drug overdose
  • Burns or trauma
  • Requirement for immediate surgery
  • CD4<50/mm3
  • Do-not-resuscitate order status
  • Transferred from another hospital

Sites / Locations

  • Carolinas Medical Center

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Active Comparator

Active Comparator

Arm Label

30cc/kg ideal body weight (IBW)

30cc/kg adjusted body weight (AdjBW)

30cc/kg actual body weight (ABW)

Arm Description

30cc/kg intravenous fluids based on the patients calculated ideal body weight will be administered when randomized to this arm Using Devine's formula. (men: 50kg + 2.3kg * (height(in) - 60); women: 45.5kg + 2.3kg * (height(in) - 60)

30cc/kg intravenous fluids based on the patients calculated adjusted body weight will be administered when randomized to this arm Calculated by the following formula: AdjBW = IBW + 0.4(ABW - IBW).

30cc/kg intravenous fluids based on the patients actual body weight will be administered when randomized to this arm Patients will receive an initial fluid bolus of 30 cc/kg of actual body weight

Outcomes

Primary Outcome Measures

Feasibility1: fluid target
percentage of of patients with actual volume received within 10% of target fluid volume.
Safety-ventilation
Proportion of patients requiring invasive or noninvasive mechanical ventilation
Safety-vasopressors
proportion of patients requiring vasopressor administration
Safety-time to hemodynamic stability
time from randomization to map >65 without use of vasopressors and no lactate >2

Secondary Outcome Measures

Exploratory: in-hospital all cause mortality
Proportion of patient in each group who experience death due to any cause during hospitalization up to 28 days
Exploratory: ICU length of stay
number of consecutive midnights in ICU
feasibility2: recruitment rate
proportion of patients enrolled out of patients screened to randomized through completion of study, an average of 1 year
feasibility3: time to randomization
median time from screening to randomization
Exploratory: hospital length of stay
number of midnights spent in hospital up to 28 days

Full Information

First Posted
February 10, 2021
Last Updated
August 10, 2022
Sponsor
Wake Forest University Health Sciences
search

1. Study Identification

Unique Protocol Identification Number
NCT04759989
Brief Title
Fluid Resuscitation in Septic Shock Patients With BMI Elevation
Acronym
FRISSBE
Official Title
Fluid Resuscitation in Septic Shock Patients With BMI Elevation
Study Type
Interventional

2. Study Status

Record Verification Date
August 2022
Overall Recruitment Status
Terminated
Why Stopped
The study is being closed due to low enrollment
Study Start Date
June 1, 2021 (Actual)
Primary Completion Date
April 25, 2022 (Actual)
Study Completion Date
May 25, 2022 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Wake Forest University Health Sciences

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
Yes

5. Study Description

Brief Summary
To explore the safety and feasibility of alternative fluid resuscitation strategies in obese patients with septic shock.
Detailed Description
Early, goal-directed therapy with timely achievement of hemodynamic stability has been shown to clearly improve outcomes in patients with septic shock. Although Surviving Sepsis Campaign guidelines recommend a weight-based approach to initial fluid resuscitation (i.e. 30ml/kg),1 at present, there are no robust data to support whether dosing based on actual body weight or an alternative correction formula (ideal body weight, adjusted body weight) is superior. FRISSBE is a prospective, randomized, three-arm parallel-group pilot trial of alternative resuscitation strategies for obese patients with septic shock, looking at feasibility and safety of different weight-based approaches. Subject treatment assignment will not be blinded. Data will be collected and analyzed on an intent-to-treat basis. The study will enroll 60 subjects, with 20 subjects per treatment arm. Subjects will be randomized to receive one of three weight-based initial fluid resuscitation strategies - 30cc/kg ideal body weight (IBW), 30cc/kg adjusted body weight (AdjBW), or 30cc/kg actual body weight (ABW).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Sepsis, Septic Shock, Obesity

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Randomized
Enrollment
7 (Actual)

8. Arms, Groups, and Interventions

Arm Title
30cc/kg ideal body weight (IBW)
Arm Type
Active Comparator
Arm Description
30cc/kg intravenous fluids based on the patients calculated ideal body weight will be administered when randomized to this arm Using Devine's formula. (men: 50kg + 2.3kg * (height(in) - 60); women: 45.5kg + 2.3kg * (height(in) - 60)
Arm Title
30cc/kg adjusted body weight (AdjBW)
Arm Type
Active Comparator
Arm Description
30cc/kg intravenous fluids based on the patients calculated adjusted body weight will be administered when randomized to this arm Calculated by the following formula: AdjBW = IBW + 0.4(ABW - IBW).
Arm Title
30cc/kg actual body weight (ABW)
Arm Type
Active Comparator
Arm Description
30cc/kg intravenous fluids based on the patients actual body weight will be administered when randomized to this arm Patients will receive an initial fluid bolus of 30 cc/kg of actual body weight
Intervention Type
Procedure
Intervention Name(s)
Actual Body Weight Dosing
Intervention Description
30cc/kg initial bolus calculated using Actual Body Weight
Intervention Type
Procedure
Intervention Name(s)
Adjusted Body Weight Dosing
Intervention Description
30cc/kg initial bolus calculated using Adjusted Body Weight
Intervention Type
Procedure
Intervention Name(s)
Ideal Body Weight Dosing
Intervention Description
30cc/kg initial bolus calculated using Ideal Body Weight
Primary Outcome Measure Information:
Title
Feasibility1: fluid target
Description
percentage of of patients with actual volume received within 10% of target fluid volume.
Time Frame
3 hours
Title
Safety-ventilation
Description
Proportion of patients requiring invasive or noninvasive mechanical ventilation
Time Frame
24 hours
Title
Safety-vasopressors
Description
proportion of patients requiring vasopressor administration
Time Frame
24 hours
Title
Safety-time to hemodynamic stability
Description
time from randomization to map >65 without use of vasopressors and no lactate >2
Time Frame
72 hours
Secondary Outcome Measure Information:
Title
Exploratory: in-hospital all cause mortality
Description
Proportion of patient in each group who experience death due to any cause during hospitalization up to 28 days
Time Frame
28 days
Title
Exploratory: ICU length of stay
Description
number of consecutive midnights in ICU
Time Frame
28 days
Title
feasibility2: recruitment rate
Description
proportion of patients enrolled out of patients screened to randomized through completion of study, an average of 1 year
Time Frame
study duration
Title
feasibility3: time to randomization
Description
median time from screening to randomization
Time Frame
3 hours
Title
Exploratory: hospital length of stay
Description
number of midnights spent in hospital up to 28 days
Time Frame
28 days

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: 18 years of age or older BMI > 30 suspected infection, and either: hypotension (a systolic blood pressure < 90mmHg) or blood lactate concentration > 4mmol/L Exclusion Criteria: Pregnant Primary diagnosis of acute cerebral vascular event Acute coronary syndrome Acute pulmonary edema Status asthmaticus Major cardiac arrhythmia Active gastrointestinal hemorrhage Seizures Drug overdose Burns or trauma Requirement for immediate surgery CD4<50/mm3 Do-not-resuscitate order status Transferred from another hospital
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Brice Taylor, MD
Organizational Affiliation
Wake Forest University Health Sciences
Official's Role
Principal Investigator
Facility Information:
Facility Name
Carolinas Medical Center
City
Charlotte
State/Province
North Carolina
ZIP/Postal Code
28203
Country
United States

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
28098591
Citation
Rhodes A, Evans LE, Alhazzani W, Levy MM, Antonelli M, Ferrer R, Kumar A, Sevransky JE, Sprung CL, Nunnally ME, Rochwerg B, Rubenfeld GD, Angus DC, Annane D, Beale RJ, Bellinghan GJ, Bernard GR, Chiche JD, Coopersmith C, De Backer DP, French CJ, Fujishima S, Gerlach H, Hidalgo JL, Hollenberg SM, Jones AE, Karnad DR, Kleinpell RM, Koh Y, Lisboa TC, Machado FR, Marini JJ, Marshall JC, Mazuski JE, McIntyre LA, McLean AS, Mehta S, Moreno RP, Myburgh J, Navalesi P, Nishida O, Osborn TM, Perner A, Plunkett CM, Ranieri M, Schorr CA, Seckel MA, Seymour CW, Shieh L, Shukri KA, Simpson SQ, Singer M, Thompson BT, Townsend SR, Van der Poll T, Vincent JL, Wiersinga WJ, Zimmerman JL, Dellinger RP. Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016. Crit Care Med. 2017 Mar;45(3):486-552. doi: 10.1097/CCM.0000000000002255.
Results Reference
background
PubMed Identifier
23786836
Citation
Wacharasint P, Boyd JH, Russell JA, Walley KR. One size does not fit all in severe infection: obesity alters outcome, susceptibility, treatment, and inflammatory response. Crit Care. 2013 Jun 20;17(3):R122. doi: 10.1186/cc12794.
Results Reference
background
PubMed Identifier
23594407
Citation
Arabi YM, Dara SI, Tamim HM, Rishu AH, Bouchama A, Khedr MK, Feinstein D, Parrillo JE, Wood KE, Keenan SP, Zanotti S, Martinka G, Kumar A, Kumar A; Cooperative Antimicrobial Therapy of Septic Shock (CATSS) Database Research Group. Clinical characteristics, sepsis interventions and outcomes in the obese patients with septic shock: an international multicenter cohort study. Crit Care. 2013 Apr 17;17(2):R72. doi: 10.1186/cc12680.
Results Reference
background
PubMed Identifier
20975548
Citation
Boyd JH, Forbes J, Nakada TA, Walley KR, Russell JA. Fluid resuscitation in septic shock: a positive fluid balance and elevated central venous pressure are associated with increased mortality. Crit Care Med. 2011 Feb;39(2):259-65. doi: 10.1097/CCM.0b013e3181feeb15.
Results Reference
background
PubMed Identifier
28130687
Citation
Marik PE, Linde-Zwirble WT, Bittner EA, Sahatjian J, Hansell D. Fluid administration in severe sepsis and septic shock, patterns and outcomes: an analysis of a large national database. Intensive Care Med. 2017 May;43(5):625-632. doi: 10.1007/s00134-016-4675-y. Epub 2017 Jan 27.
Results Reference
background
PubMed Identifier
28823951
Citation
Taylor SP, Karvetski CH, Templin MA, Heffner AC, Taylor BT. Initial fluid resuscitation following adjusted body weight dosing is associated with improved mortality in obese patients with suspected septic shock. J Crit Care. 2018 Feb;43:7-12. doi: 10.1016/j.jcrc.2017.08.025. Epub 2017 Aug 15.
Results Reference
background

Learn more about this trial

Fluid Resuscitation in Septic Shock Patients With BMI Elevation

We'll reach out to this number within 24 hrs